Concurrent administration of vinorelbine with recombinant human granulocyte colony-stimulating factor: an effective method of increasing dose intensity.

@article{Weiss1999ConcurrentAO,
  title={Concurrent administration of vinorelbine with recombinant human granulocyte colony-stimulating factor: an effective method of increasing dose intensity.},
  author={Aaron Josef Weiss and Jennifer L. Sabol and Richard D. Lackman},
  journal={American journal of clinical oncology},
  year={1999},
  volume={22 1},
  pages={
          38-41
        }
}
Thirty-three patients with incurable neoplasms resistant to standard therapy received vinorelbine 8 mg/m2 to 10 mg/m2 per day by continuous infusion with concurrent administration of recombinant human granulocyte colony-stimulating factor 5 microm/m2 per day. The duration of the vinorelbine infusion was individualized; the infusion was continued until early evidence of hematopoietic toxicity was noted. The concurrent administration of recombinant human granulocyte colony-stimulating factor… CONTINUE READING
BETA